Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Myelodysplastic syndrome (MDS)
Closed
Phase 3
This trial is looking at using lenalidomide (Revlimid) for myelodysplastic syndrome (MDS).
Recruitment start: 9 February 2010
Recruitment end: 31 May 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Vyas
Celgene Corporation
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 15 Feb 2016
CRUK internal database number: 7971
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
